Although government enforcement in some areas may not be what it has been in the past, there has been an increasingly active docket of antitrust cases across the health care industry, including Cascade Health, Evanston, and the recent filing by 19 States in Florida v. Abbott Laboratories. Join Mark Waxman and David Simon of Foley & Lardner LLP, as they discuss the major cases and governmental enforcement initiatives over the past year in this latest installment of our new series on health care law. Topics include: 1. Bundling and allegations of monopoly leveraging; 2. Conspiracies to set wages in the market for nurses; 3. Exclusive contracting in the managed care arena; 4. Threatened boycotts to address the threat of new physician-hospital competition; 5. Covenants not to compete and their validity in hospital-physician relationships; 6. A look at hospital mergers and Evanston; and 7. The attack on "generic blocking" in the pharmaceutical market.